Сучасні підходи до хірургічного та постхірургічного медикаментозного ведення пацієнток із ендометріозом

In: 2309-4117 · 2017 · W7113716121
article OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex
⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-11 · read from full text ⓘ

This paper reviews modern approaches to the surgical and post-surgical medical management of patients with endometriosis, emphasizing a combined strategy to minimize recurrence. It outlines that while surgery addresses immediate lesions, long-term hormonal therapy lasting more than six months is recommended for secondary prevention of pain and lesion return. The text specifies that surgeons play a key role in prescribing postsurgical treatment, particularly recommending dienogest for three to six months depending on disease infiltration, especially in cases involving infertility. This paper is centrally about endometriosis — specifically focusing on integrated surgical and hormonal protocols for managing the disease and preventing recurrence.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

December 8, 2016 in Kyiv Advisory Board was held related to modern approaches to surgical and postsurgical medical management of patients with endometriosis. Endometriosis is a chronic estrogen-dependent gynecological disease which requires a life-long management plan with the goal of maximizing the use of medical treatment and avoiding repeated surgical procedures. The disease management tactics in patients with endometriosis are determined by the clinical symptoms and includes observation, medical treatment, surgical treatment (conservative, radical), using of the assisted reproductive technologies. To prevent endometriosis recurrence it is reasonable to use a combined approach – surgical methods and hormonal therapy.In resolution surgical tactics of management of patients with endometriosis is described in detail based on clinical symptoms and appropriate conditions for this intervention, according to the unified clinical protocol “Management of patients with genital endometriosis” approved by Order of Ministry of Health of Ukraine No. 319 dated April 06, 2016.Postsurgical prevention of endometriosis recurrence is an important stage of management of patients with endometriosis, as regardless of the proven efficacy of the surgical treatment, a risk of endometriosis lesions and pain recurrence is exist.As noted in the resolution, currently no clear criteria for endometriosis recurrence evaluation are available. The hormonal therapy may maintain the positive effect of the surgical treatment for a long time and may minimize the risk of pain and endometrioid lesions recurrence. For secondary prevention of endometriosis recurrence and associated pain long-term hormonal therapy is recommended (> 6 months). A surgeon plays a key role in prescription of postsurgical medical treatment: he/she determines its strategy for the first 6 months after the surgery in alignment with the outpatient physician.To treat the women with endometriosis and infertility, the surgeon should have the appropriate skills and experience. Cooperation with the centers of reproductive medicine is also mandatory. In persistent infertility (failure of long-term therapy) of non-defined origin and suspected endometriosis (presence of pain syndrome), it is reasonable to perform the laparoscopy to rule out the endometriosis as a cause of infertility and its surgical treatment. After surgery, the patients with the reproductive plans are recommended to prescribe dienogest for 3 months and in case of infiltrating endometriosis forms – at least for 6 months to minimize the inflammatory process. As its noted in resolution medical and surgical methods of endometriosis treatment should not be considered as competitive but as compatible, which increase the treatment efficacy and improve the disease prognosis.
Full text 8,325 characters · extracted from oa-html · click to expand
Modern approaches to surgical and postsurgical medical management of patients with endometriosis DOI: https://doi.org/10.18370/2309-4117.2017.34.8-14Keywords: endometriosis, infertility, surgical methods, hormonal therapy, secondary preventionAbstract December 8, 2016 in Kyiv Advisory Board was held related to modern approaches to surgical and postsurgical medical management of patients with endometriosis. Endometriosis is a chronic estrogen-dependent gynecological disease which requires a life-long management plan with the goal of maximizing the use of medical treatment and avoiding repeated surgical procedures. The disease management tactics in patients with endometriosis are determined by the clinical symptoms and includes observation, medical treatment, surgical treatment (conservative, radical), using of the assisted reproductive technologies. To prevent endometriosis recurrence it is reasonable to use a combined approach – surgical methods and hormonal therapy. In resolution surgical tactics of management of patients with endometriosis is described in detail based on clinical symptoms and appropriate conditions for this intervention, according to the unified clinical protocol “Management of patients with genital endometriosis” approved by Order of Ministry of Health of Ukraine No. 319 dated April 06, 2016. Postsurgical prevention of endometriosis recurrence is an important stage of management of patients with endometriosis, as regardless of the proven efficacy of the surgical treatment, a risk of endometriosis lesions and pain recurrence is exist. As noted in the resolution, currently no clear criteria for endometriosis recurrence evaluation are available. The hormonal therapy may maintain the positive effect of the surgical treatment for a long time and may minimize the risk of pain and endometrioid lesions recurrence. For secondary prevention of endometriosis recurrence and associated pain long-term hormonal therapy is recommended (> 6 months). A surgeon plays a key role in prescription of postsurgical medical treatment: he/she determines its strategy for the first 6 months after the surgery in alignment with the outpatient physician. To treat the women with endometriosis and infertility, the surgeon should have the appropriate skills and experience. Cooperation with the centers of reproductive medicine is also mandatory. In persistent infertility (failure of long-term therapy) of non-defined origin and suspected endometriosis (presence of pain syndrome), it is reasonable to perform the laparoscopy to rule out the endometriosis as a cause of infertility and its surgical treatment. After surgery, the patients with the reproductive plans are recommended to prescribe dienogest for 3 months and in case of infiltrating endometriosis forms – at least for 6 months to minimize the inflammatory process. As its noted in resolution medical and surgical methods of endometriosis treatment should not be considered as competitive but as compatible, which increase the treatment efficacy and improve the disease prognosis. References - Management of patients with endometriosis. Unified clinical protocol of primary, secondary (specialized) and tertiary (highly specialized) medical care, approved by the Order of the Ministry of Health of Ukraine № 319 from 06.04.2016. - Sinaii Ninet, et al. “Differences in characteristics among 1,000 women with endometriosis based on extent of disease.” Fertil Steril 89.3 (2008): 538–45. - Schliep, K.C., et al. “Pain typology and incident endometriosis.” Hum Reprod 30.10 (2015): 2427–38. - McKinnon, B.D., Bertschi, D., Bersinger, N.A., Mueller, M.D. “Inflammation and nerve fiber interaction in endometriotic pain.” Trends Endocrinol Metab 26.1 (2015): 1–10. - Mettler, L., Ruprai, R., Alkatout, I. “Impact of medical and surgical treatment of endometriosis on the cure of endometriosis and pain.” Biomed Res Int (2014): 264653. - Kennedy S., et al. “ESHRE guideline for the diagnosis and treatment of endometriosis.” Hum Reprod 20 (2005): 2698–704. - Ulricha, U., De Wild, R.L. “New guidelines on diagnosis and treatment of endometriosis in German-speaking countries.” Gynecology and Minimally Invasive Therapy 5.1 (2016): 41–3. - Dunselman, G.A., et al. “ESHRE guideline: management of women with endometriosis.” Hum Reprod 29.3 (2014): 400–12. - Koga, K., et al. “Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis.” Fertility and Sterility 104.4 (2015): 793–801. - Johnson, N.P., Hummelshoj, L. “Consensus on Current Management of Endometriosis.” Hum Reprod 28.6 (2013): 1552–68. - Practice Committee of the American Society for Reproductive Medicine. “Treatment of pelvic pain associated with endometriosis.” Fertil Steril 90 Suppl 5 (2008): 260–9. - Leyland, N., et al. “Endometriosis: diagnosis and management.” J Obstet Gynaecol Can 32.7 Suppl 2 (2010): 1–32. 10.1016/S1701-2163(16)34589-3 - Fenton, A., Panay, N. “Does routine gynecological surgery contribute to an early menopause?” Climacteric 15.1 (2012): 1–2. - Koga, K., et al. “Recurrence of endometrioma after laparoscopic excision and its prevention by medical management.” Frontiers in Bioscience 5 (2013): 676–83. - Guo, S.W. ”Recurrence of endometriosis and its control.” Hum Reprod Update 15.4 (2009): 441–61. - Cocciaa, M.E., et al. “European Long-term follow-up after laparoscopic treatment for endometriosis: multivariate analysis of predictive factors for recurrence of endometriotic lesions and pain.” J Obst Gyn Repr Biol 157.1 (2011): 78–83. - Somigliana, E., et al. “Postoperative Medical Therapy After Surgical Treatment of Endometriosis: From Adjuvant Therapy to Tertiary Prevention.” J Minim Invasive Gynecol 21.3 (2014): 328–34. - Namnoum, A.B., et al. “Incidence of symptom recurrence after hysterectomy for endometriosis.” Fertil Steril 64.5 (1995): 898–902. - Busacca, M., et al. “Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis.” Am J Obst Gyn 195 (2006): 426–32. - Busacca, M., et al. “The current place of progestins in the treatment of endometriosis.” Expert Review of Obstetrics & Gynecology 7.2 (2012). - Ota, Y., et al. “Long-term administration of dienogest reduces recurrence after excision of endometrioma.” Journal of Endometriosis and Pelvic Pain Disorders 7.2 (2015): 63–7. - Schweppe, K.-W. “The current place of progestins in the treatment of endometriosis.” Expert Rev of Obstet Gynecol 7.2 (2012): 141–8. - Bahamondes, L., et al. “Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.” Contraception 75 (2007) : 134–9. - Serdar, E., et al. “Role of Estrogen Receptor-β in Endometriosis.” Nat Med 18.7 (2012): 1016–8. - Chapron, C., et al. “Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis.” Hum Reprod 26.8 (2011): 2028–35. - Seracchioli, R. “Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom recurrence after conservative surgery for endometriosis.” Hum Reprod 24.11 (2009): 2729–35. - Seracchioli, R., et al. “Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial.” Fertil Steril 94.2 (2010): 464–71. Downloads Published How to Cite Issue Section License Copyright (c) 2017 В. В. Камінський, Т. Ф Татарчук, І. З. Гладчук, М. Мюллер This work is licensed under a Creative Commons Attribution 4.0 International License. Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK